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Natural killer cells attack tumor cells, infected cells and
some normal cells, but the basis of their specificity is
not completely understood. Recent studies indicate that
epithelial tumor cells upregulate a stress-induced MHC
class-I-like protein termed MICA, triggering NK cells via
a recently described receptor called NKG2D. 
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At one time, natural killer (NK) cells were considered
boring. Little was understood about their specificity or
their biological role. They were known to be lymphocytes
that secrete cytokines and mediate direct cytotoxicity, and
were thought to play an important role in tumor rejection
and immunity to viruses and other infections, but that was
the extent of our knowledge. In recent years, many recep-
tors expressed on the surface of NK cells have been
identified and several interesting concepts have been
advanced concerning their mode of recognition. NK cells
are now anything but boring, although great holes still
persist in our understanding of them. 
Although there is now an embarrassment of NK receptors,
the functions of many of them are currently conjectural.
Moreover, none of these receptors fits the bill of ‘the NK
receptor’, analogous to the B- or T-cell receptors that are
the major source of specificity for activation on those lym-
phocytes. As will be discussed below, this is likely to
reflect a real difference between the recognition strategies
used by T cells, which are relatively single-minded, and
NK cells, which use many different types of stimulatory
receptors. Nevertheless, some stimulatory NK cell recep-
tors may be more interesting than others. As described in
two recent reports [1,2], a recently cloned NK receptor,
NKG2D, may have a critical role in the recognition of
tumor cells by NK cells via binding to stress-induced
ligands that are related to major histocompatibility
complex (MHC) class I molecules. 
Activation of NK cells is an early event during an immune
response and does not involve the expansion of rare,
antigen-specific cells as is characteristic of the adaptive
immune response. NK cells are therefore part of the
innate, immediate-acting arm of the immune system. NK
cells can attack normal (non-self) cells under certain
conditions, but they generally exhibit stronger activity
against tumor cells and virus-infected cells. A key princi-
ple of the specificity of NK cells was revealed by studies
showing that NK cells prefer to attack cells that have
downregulated classical MHC class I molecules. The
‘missing self hypothesis’ [3] proposes that this function of
NK cells serves to protect the host against transformed
cells and infected cells, both of which often downregulate
expression of MHC class I proteins to escape recognition
by cytotoxic T cells. 
Great progress has been made in understanding how NK
cells detect loss of MHC class I molecules on target
cells. NK cells express inhibitory MHC class-I-specific
receptors from at least three families of proteins: two
C-type lectin families, the CD94–NKG2 heterodimeric
receptors (in humans and mice) and Ly49 (in mice), and
the killer cell immunoglobulin-like receptor (KIR)
family (in humans) [4]. These inhibitory receptors all
contain an immunoreceptor tyrosine-based inhibitory
motif (ITIM) in their cytoplasmic domains that binds to
the Src homology 2 (SH2) domain of protein phos-
phatases, such as SHP-1 and possibly SHP-2. Loss of
MHC class I expression on target cells prevents the
inhibitory interaction between the NK cell and the target
cell, and thereby unleashes the NK cell. But although
inhibitory recognition of MHC class I molecules plays an
important role in regulating NK cell activity, the sensi-
tivity of target cells to NK cells does not always correlate
with MHC class I expression [5]. Thus, NK cell activa-
tion may require interactions with stimulatory ligands on
target cells. The decision whether to attack a target cell
would then be determined by the balance of stimulatory
and inhibitory interactions. 
So what stimulates NK cells to attack target cells? A new
and exciting candidate that triggers NK cells to attack
tumor cells is the non-classical MHC class I molecule
termed MICA (for MHC I chain-related-A). The 43 kDa
MICA glycoprotein and a close relative, MICB, are
encoded by genes located near the locus for the human
MHC class I molecule HLA-B [6]. Unlike most MHC
class I molecules, MICA is not associated with β2
microglobulin and probably does not bind peptide.
Interestingly, the MIC gene transcriptional regulatory
sequences contain heat-shock elements similar to those in
the human Hsp70 promoter [7]. Indeed, MICA expression
is substantially upregulated following heat-shock treat-
ment of various intestinal cell lines. As also observed for
some other stress-induced proteins, MIC expression is
also upregulated on many epithelial tumors [8]. 
These interesting findings suggested that MIC expression
could be a flag raised by tumor cells to recruit anti-tumor
lymphocytes such as T cells or NK cells. Indeed, target
cells transfected with MICA were susceptible to attack by
intestinal epithelial T-cell lines expressing Vδ1 γδ T-cell
receptors [9]: γδ T cells represent a small proportion of the
total T-cell population and relatively little is known about
their function. MICA-positive tumors were predominantly
infiltrated by Vδ1 γδ T cells. These results suggested that
MIC molecules are stress-induced antigens recognized by
γδ T cells, which could play an important role in the sur-
veillance of transformed, infected and damaged cells. 
As it is now well established that other MHC class I mole-
cules can be targets of both T-cell receptors and NK
receptors, it should perhaps be no surprise that MIC mol-
ecules are no exception. Bauer et al. [1] provide striking
evidence that soluble multimeric MICA binds to essen-
tially all NK cells and cytotoxic CD8+ T cells. They show
that the receptor for MICA on these cells is NKG2D, a
receptor expressed by NK cells in both humans [10] and
mice [11]. NKG2D is a C-type lectin encoded in the NK
receptor gene complex. Despite its name, NKG2D is no
more related to NKG2A, B, C and E receptors than to
other receptors encoded in the NK receptor gene
complex. It does not associate with CD94 and does not
exhibit the same specificity as CD94–NKG2A receptors. 
Bauer et al. [1] report that binding of MICA on target cells
to NKG2D on NK cells strongly induces cytotoxic activity
in the NK cell, even overriding inhibitory signals pro-
vided by the same target cell. The cytotoxicity of a human
NK cell clone against MIC-expressing tumor cell lines
was at least partially dependent on the recognition of
MICA by NKG2D. The finding that a stress-inducible
MHC class-I-like ligand is targeted by NK cells repre-
sents the best elucidated instance of how the innate
immune system can target transformed cells and raises the
question of whether MIC molecules are induced in
infected cells as well. Given the binding of MICA to
CD8+ T cells, the possible role of NKG2D in these cells
is also intriguing. 
NKG2D contains a positive charge in its transmembrane
domain, a hallmark of all activating NK receptors. The
positive charge promotes interactions with acidic residues
in the transmembrane domains of adaptor proteins, most
of which contain immunoreceptor tyrosine-based activa-
tion motifs (ITAMs) for the recruitment of protein tyro-
sine kinases. NK cells express several adaptor proteins,
including the CD3ζ signalling chain of the T-cell recep-
tor, Fcγ receptor and a recently identified protein called
DAP12 (originally named KARAP) [12]. DAP12 associates
with several stimulatory NK receptors and initially
seemed a good candidate for the adaptor protein of
NKG2D. Instead, Wu et al. [2] found that NKG2D associ-
ates with a newly discovered adaptor protein, DAP10,
which is expressed in a variety of hematopoietic cells.
DAP10 and DAP12 are extremely closely linked on
human chromosome 19q13.1, but differ considerably in
their amino acid sequences. Surprisingly, the DAP10 cyto-
plasmic domain may not contain an ITAM, but instead
contains an SH2-binding YxxM motif (in single-letter
amino acid code with x representing any amino acid) that
appears to recruit the p85 catalytic subunit of phos-
phatidylinositol (PI) 3-kinase. Interestingly, the T-cell
costimulatory molecule CD28 contains a similar motif.
Precisely how NKG2D activates NK cells and whether it
also requires reinforcing stimulatory signals — as is the
case with CD28 — remains to be determined. 
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Figure 1
MICA, NKG2D and NK cell recognition.
Normal epithelial cells inhibit NK cells via
inhibitory MHC class-I-specific receptors (KIR),
which recruit and activate the protein tyrosine
phosphatase SHP-1. Dephosphorylation of
activating signal molecules by SHP-1 prevents
NK cell activation. Cellular transformation
leads to induction of stress proteins including
MICA (‘stress out’). Recognition of MICA by
NKG2D–DAP10 ‘turns on’ the NK cell.
Engaging the NKG2D receptor complex
induces binding of the p85 subunit of PI
3-kinase to a YxxM motif in the DAP10
cytoplasmic domain, leading to NK cell
activation. Inhibitory recognition of MHC class
I molecules could moderate or ‘tune’ the
activating signal. Maximal NK cell activation
would occur when the target cell
downregulates MHC class I molecules as
































Taken together, these recent studies provide a plausible
model for at least one mode of recognition of malignant
cells by NK cells (Figure 1): patrolling NK cells receive
only weak activating signals from normal cells, and these
signals are nullified by the inhibitory recognition of self-
MHC class I molecules. Stress signals that accompany cel-
lular transformation upregulate MIC, which is recognized
by the stimulatory NKG2D–DAP10 receptor. If these
stimulatory signals are sufficiently strong, they may over-
come inhibition mediated by inhibitory recognition of
classical MHC class I molecules. If the offending cell has
also downregulated classical MHC class I molecules, the
balance would swing even further in favor of activation of
the NK cell. This model can account for the fact that some
tumor cells are susceptible to NK cells despite expressing
normal levels of classical MHC class I molecules, whereas
other cells are resistant to NK cells despite expressing low
levels of classical MHC class I molecules.
Interestingly, the human proteins NKG2D and DAP10
are quite conserved in mice [2,11], but there is no obvious
murine MIC ortholog. An interesting parallel concerns
the CD94–NKG2 receptors. The human and mouse
ligands for these receptors, the nonclassical MHC class I
proteins HLA-E and Qa-1b, respectively, are clearly func-
tional homologs. Their overall sequences are no more
similar, however, than any pair of unrelated MHC class I
proteins in mouse and human. Perhaps the functional
MIC homolog in mice is also quite divergent in sequence
from its human counterpart.
The centrality of NKG2D to NK cell activation remains to
be established. For one thing, most hematopoietic tumor
cell lines do not express MIC molecules [6], yet many are
highly sensitive to NK cells. Indeed, NK cells express a
plethora of other stimulatory receptors. Among these are
close relatives of the inhibitory, MHC class-I-specific
receptors. Several of these stimulatory isoforms are spe-
cific for the same MHC class I molecules that are recog-
nized by their inhibitory relatives. Other activating
molecules on NK cells are the NKR-P1A and C mole-
cules, whose natural ligands have not been identified. NK
cell lines lacking NKR-P1 molecules exhibited reduced
capacity to attack one tumor cell line that was tested, but
not several others [13]. Recent studies in the human
system have identified two new immunoglobulin-like NK
cell receptors — NKp44 and NKp46 — that may be
involved in recognition of some tumor cells [14]. These
receptors probably recognize non-MHC ligands on target
cells, but the nature of these ligands is not established.
A key difference between the stimulatory receptors
expressed by NK cells and those of B and T cells is that
many of the stimulatory NK receptors are co-expressed by
individual NK cells. It appears that NK cells use several
optional triggering receptors, which may differ in specificity
but target overlapping sets of susceptible cells. It is as if an
NK cell, given access to receptors of relatively limited
diversity, equips itself with a large variety of them,
whereas individual T and B cells make do with a single
highly sophisticated and more specific model. This state
of affairs befits the differing strategies inherent in the
innate versus adaptive immune response. Much effort is
being exerted to identify new stimulatory receptors on
NK cells, and to determine their biological function. We
can expect lots of new surprises to come as research on the
enigmatic NK cell progresses. 
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